Student or educator? Sign up with your school email and get 6 months of Pro free.
CoChat
Sign Up
Cited by 132

The DOI matches its Crossref record; 9 of the 9 references it cites were found in a registry or an index.

The impact of peppermint oil on the irritable bowel syndrome: a meta-analysis of the pooled clinical data

Alammar, N., Wang, L., Saberi, B., Nanavati, J., Holtmann, G., Shinohara, R. T., Mullin, G. E.·2019·BMC Complementary and Alternative Medicine
DOI 10.1186/s12906-018-2409-0
Open this paper in CoChat — free account

Overview

The claims and statistics of this paper haven’t been checked yet.

Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.

A few free checks a day · papers already verified open instantly · results are public

Integrity signals

Registry

Crossref · 10.1186/s12906-018-2409-0

Cites

9 of 9 references verified0 citation errors · 0 not checkable

Statistics

Verification

Claims the paper makes

The claims and statistics of this paper haven’t been checked yet.

Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.

A few free checks a day · papers already verified open instantly · results are public

Claims other papers make about this one

Each is checked against this paper’s own text: does it say what the citing paper says it does?

Self-check

Percentages, sums and reported differences re-computed from the paper’s own numbers.

The self-check needs the paper’s full text.

Citations

Cites

Show all 9 references

Research works printed but not linked: 36

  1. Choung RS, Locke GR 3rd. Epidemiology of IBS. Gastroenterol Clin N Am. 2011;40(1):1–10. · DOI
  2. Buono JL, Carson RT, Flores NM. Health-related quality of life, work productivity, and indirect costs among patients with irritable bowel syndrome with diarrhea. Health Qual Life Outcomes. 2017;15(1):35. · DOI
  3. Oswiecimska J, Szymlak A, Roczniak W, Girczys-Poledniok K, Kwiecien J. New insights into the pathogenesis and treatment of irritable bowel syndrome. Adv Med Sci. 2017;62(1):17–30. · DOI
  4. Mullin GE, Shepherd SJ, Chander Roland B, Ireton-Jones C, Matarese LE. Irritable bowel syndrome: contemporary nutrition management strategies. JPEN J Parenter Enteral Nutr. 2014;38(7):781–99. · DOI
  5. Ford AC, Talley NJ, Spiegel BM, Foxx-Orenstein AE, Schiller L, Quigley EM, et al. Effect of fibre, antispasmodics, and peppermint oil in the treatment of irritable bowel syndrome: systematic review and meta-analysis. BMJ. 2008;337:a2313. · DOI · Paper page
  6. Hawthorn M, Ferrante J, Luchowski E, Rutledge A, Wei XY, Triggle DJ. The actions of peppermint oil and menthol on calcium channel dependent processes in intestinal, neuronal and cardiac preparations. Aliment Pharmacol Ther. 1988;2(2):101–18. · DOI · Paper page
  7. de Sousa Guedes JP, da Costa Medeiros JA, de Souza ESRS, de Sousa JM, da Conceicao ML, de Souza EL. The efficacy of Mentha arvensis L. and M. piperita L. essential oils in reducing pathogenic bacteria and maintaining quality characteristics in cashew, guava, mango, and pineapple juices. Int J Food Microbiol. 2016;238:183–92. · DOI
  8. McKay DL, Blumberg JB. A review of the bioactivity and potential health benefits of peppermint tea (Mentha piperita L.). Phytother Res. 2006;20(8):619–33. · DOI · Paper page
  9. Grigoleit HG, Grigoleit P. Gastrointestinal clinical pharmacology of peppermint oil. Phytomedicine. 2005;12(8):607–11. · DOI
  10. Ford AC. Effect of fibre, antispasmodics, and peppermint oil in the treatment of irritable bowel syndrome: systematic review and meta-analysis (vol 337, a2313, 2008). Br Med J. 2009;338.
  11. Pittler MH, Ernst E. Peppermint oil for irritable bowel syndrome: a critical review and metaanalysis. Am J Gastroenterol. 1998;93(7):1131–5. · DOI · Paper page
  12. Huertas-Ceballos A, Logan S, Bennett C, Macarthur C. Pharmacological interventions for recurrent abdominal pain (RAP) and irritable bowel syndrome (IBS) in childhood. Cochrane Database Syst Rev. 2008;(1):CD003017. https://doi.org/10.1002/14651858.CD003017.pub2 . · DOI
  13. Mann N, Sandhu K. Peppermint oil in irritable bowel syndrome: evaluation of 1634 cases with qualitative meta-analysis. Am J Gastroenterol. 2010;105:S481–S2. · DOI
  14. Mann NS, Sandhu KS. Peppermint oil in irritable bowel syndrome: systematic evaluation of 1634 cases with meta-analysis. Int Med J. 2012;19(1):5–6.
  15. Khanna R, MacDonald JK, Levesque BG. Peppermint oil for the treatment of irritable bowel syndrome: a systematic review and meta-analysis. J Clin Gastroenterol. 2014;48(6):505–12. · DOI
  16. Rees WD, Evans BK, Rhodes J. Treating irritable bowel syndrome with peppermint oil. Br Med J. 1979;2(6194):835–6. · DOI
  17. Lesbros-Pantoflickova D, Michetti P, Fried M, Beglinger C, Blum AL. Meta-analysis: the treatment of irritable bowel syndrome. Aliment Pharmacol Ther. 2004;20(11–12):1253–69. · DOI
  18. Cash BD, Epstein MS, Shah SM. A novel delivery system of peppermint oil is an effective therapy for irritable bowel syndrome symptoms. Dig Dis Sci. 2016;61(2):560–71. · DOI
  19. Liberati A, Altman DG, Tetzlaff J, Mulrow C, Gotzsche PC, Ioannidis JP, et al. The PRISMA statement for reporting systematic reviews and meta-analyses of studies that evaluate health care interventions: explanation and elaboration. PLoS Med. 2009;6(7):e1000100. · DOI · Paper page
  20. Sayers A. Tips and tricks in performing a systematic review. Br J Gen Pract. 2007;57(538):425.
  21. Alam MS, Roy PK, Miah AR, Mollick SH, Khan MR, Mahmud MC, et al. Efficacy of peppermint oil in diarrhea predominant IBS - a double blind randomized placebo - controlled study. Mymensingh medical journal : MMJ. 2013;22(1):27–30.
  22. Cappello G, Spezzaferro M, Grossi L, Manzoli L, Marzio L. Peppermint oil (Mintoil((R))) in the treatment of irritable bowel syndrome: a prospective double blind placebo-controlled randomized trial. Dig Liver Dis. 2007;39(6):530–6. · DOI · Paper page
  23. Capanni M, Surrenti E, Biagini MR, Milani S, Surrenh C, Galli A. Efficacy of peppermint oil in the treatment of irritable bowel syndrome: a randomized, controlled trial. Gazz med ital arch sci med [Internet]. 2005; 164(2):119–26.
  24. Merat S, Khalili S, Mostajabi P, Ghorbani A, Ansari R, Malekzadeh R. The effect of enteric-coated, delayed-release peppermint oil on irritable bowel syndrome. Dig Dis Sci. 2010;55(5):1385–90. · DOI · Paper page
  25. Dew MJ, Evans BK, Rhodes J. Peppermint Oil for the Irritable Bowel Syndrome - a Multicenter Trial. Br J Clin Pract. 1984;38(11–1):394.
  26. Lech Y, Olesen KM, Hey H, Rask-Pedersen E, Vilien M, Ostergaard O. Treatment of irritable bowel syndrome with peppermint oil. A double-blind investigation with a placebo. Ugeskr Laeger. 1988;150(40):2388–9.
  27. Liu JH, Chen GH, Yeh HZ, Huang CK, Poon SK. Enteric-coated peppermint-oil capsules in the treatment of irritable bowel syndrome: a prospective, randomized trial. J Gastroenterol. 1997;32(6):765–8. · DOI · Paper page
  28. Weiss WKC. Treatment of irritable bowel syndromewith peppermint oil capsules: results of a double blind study. Therapiewoche Osterreich. 1988;3:3–8.
  29. Carling L, Svedberg LE, Hulten S. Short term treatment of the irritable bowel syndrome: a placebo-controlled trial of peppermint oil against hyoscyamine. Opuscula Medica. 1989;34(3):55–7.
  30. Nash P, Gould SR, Bernardo DE. Peppermint oil does not relieve the pain of irritable bowel syndrome. Br J Clin Pract. 1986;40(7):292–3. · DOI
  31. Jadad AR, Moore RA, Carroll D, Jenkinson C, Reynolds DJ, Gavaghan DJ, et al. Assessing the quality of reports of randomized clinical trials: is blinding necessary? Control Clin Trials. 1996;17(1):1–12. · DOI · Paper page
  32. Czalbert HJNM, Feher K. Experiences with colpermintherapy (Tillots-England) at patients of irritable colon syndrome. Gyogyszereszet. 1990;34(5):251–3.
  33. Kline RM, Kline JJ, Di Palma J, Barbero GJ. Enteric-coated, pH-dependent peppermint oil capsules for the treatment of irritable bowel syndrome in children. J Pediatr. 2001;138(1):125–8. · DOI · Paper page
  34. Ford AC, Moayyedi P, Lacy BE, Lembo AJ, Saito YA, Schiller LR, et al. American College of Gastroenterology monograph on the management of irritable bowel syndrome and chronic idiopathic constipation. Am J Gastroenterol. 2014;109( Suppl 1):S2–26; quiz S7. · DOI
  35. Mosaffa-Jahromi M, Lankarani KB, Pasalar M, Afsharypuor S, Tamaddon AM. Efficacy and safety of enteric coated capsules of anise oil to treat irritable bowel syndrome. J Ethnopharmacol. 2016;194:937–46. · DOI
  36. Klein KB. Treatment of the irritable bowel syndrome. Drugs of Today. 1988;24(8):589–95.

Cited by

Metadata

Authors
Alammar, N., Wang, L., Saberi, B., Nanavati, J., Holtmann, G., Shinohara, R. T., & Mullin, G. E.
Venue
BMC Complementary and Alternative Medicine
Publisher
Springer Science and Business Media LLC
Published
2019-01-17
Volume
19
Issue
1
ISSN
1472-6882
DOI
10.1186/s12906-018-2409-0
Cited by
132
References
9
Language
en
Licence
creativecommons.org/licenses/by/4.0/ (tdm)

About these checks

Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.

Statistics and arithmetic are recomputed, not judged.

Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.

What counts as a claim ›How we measure confidence ›How we check this ›

Are you an author, or do you see a problem with this page? Request a review

Data sources

Bibliographic data: Semantic Scholar, OpenAlex, Crossref.

Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).

Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.